These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: High-dose intravenous immune globulin impairs antibacterial activity of antibiotics.
    Author: Kim KS.
    Journal: J Allergy Clin Immunol; 1989 Oct; 84(4 Pt 2):579-86; discussion 586-8. PubMed ID: 2677094.
    Abstract:
    In an effort to examine further whether passive immunotherapy is a useful adjunct to antimicrobial therapy for neonatal group B streptococcal disease, we evaluated human intravenous immune globulin and penicillin G, alone and in combination, for their therapeutic efficacy against experimental severe group B streptococcal infection in newborn rats. Infected rats received either immunoglobulin (2 gm/kg) intraperitoneally, penicillin G (dosage varied), or a combination of the two. All animals that received immunoglobulin alone died. The mortality rate of animals treated with penicillin G alone was 51%. In contrast, therapy with combined penicillin G and immunoglobulin resulted in a significantly greater mortality rate (88%). Similar detrimental effects were also observed when human immunoglobulin (2 gm/kg) was given in conjunction with ceftriaxone (mortality rates of 95.7% for ceftriaxone and immunoglobulin versus 56.5% for ceftriaxone alone). However, a smaller dose of immunoglobulin (0.5 gm/kg) did not result in the greater mortality rate. Moreover, antibiotic-mediated bacterial killing was impaired in vitro and in vivo by a large dose of immunoglobulin but not by a smaller dose. These findings suggest that large doses of human immunoglobulin may be disadvantageous to the bacterial activity of penicillin G and ceftriaxone against group B streptococcal disease. Additional studies are needed to elucidate further the mechanisms responsible for this dose-dependent adverse effect of human immunoglobulins.
    [Abstract] [Full Text] [Related] [New Search]